Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The florida tggi pump crew is usless. I have never seen a post about a lawsuit filed against igpk on this board. Matt dywers pump crew on this board are twisted.
Your gonna miss the money train bro. Any day this shit will blast off.
If Diamond CBD makes THC products. I would probably never buy flower or any other product anywhere else. I invested everything I have in POTN. Diamond CBD will take ovrr the Earths Cannabis Industry when they legalizer THC in USA. Diamond CBD-THC is the Future.
Diamond THC will take over the weed game. Honestly, I would never by flower again if Diamond made THC products
Probably even 7.93
Probably to early. Wait for 8.10
Sold 40 diamond CBD items in the past 2 weeks. I have had 100% customer satisfaction
Not if you bought trips...
I'd love to hear of a really shady MM getting whacked.
Based on the mad money interview, I don't think CVS is going to carry Diamond CBD products...
lol.. This company is real. I've done extensive dd and been waiting for the right time. buckle up!
Been watching this company forever. It's ready to explode to Saturn!
Press Release: Marijuana Company of America Acquires Interest in Licensed California Manufacturing & Distribution Company
3/20/19 8:00 AM ET (Dow Jones)Print
Press Release: Marijuana Company of America Acquires Interest in Licensed California Manufacturing & Distribution Company
Marijuana Company of America Acquires Interest in Licensed California Manufacturing & Distribution Company
ESCONDIDO, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- MARIJUANA COMPANY OF AMERICA INC. ("MCOA" or the "Company") (OTC: MCOA), an innovative hemp and cannabis corporation, is pleased to announce that MCOA has entered into a letter of intent (LOI) with Natural Plant Extract of California (NPE) and its subsidiary, Northern Lights Distribution, LLC (NLD), to acquire a 20% ownership interest in NPE, and to establish a Joint Venture (JV) to operate a California cannabis delivery service named Viva Buds.
Under the terms of the LOI, MCOA has committed to contribute $2,000,000 in total cash to the project, as well as common shares of the Company with a value of $1,000,000. In exchange, MCOA will own a 20% equity position in NPE. In addition, both NPE and MCOA will form a JV to operate Viva Buds and will share in the profits on a 50/50 basis.
NPE has obtained both state and city licenses for volatile manufacturing, distribution and retail delivery of cannabis products. NPE has a long-term lease with favorable terms for its location at 11116 Wright Road, Lynwood, CA. NPE will manage all operations pertaining to distribution, manufacturing, and delivery of cannabis products, and MCOA will provide capital, consulting and marketing services. NPE is currently generating revenue through its distribution business segment under NLD, which it launched in 2018 and is undergoing construction of its manufacturing lab since it recently obtained all of the necessary state and local permits.
As part of the JV with NPE's distribution company NLD, MCOA formed a wholly owned subsidiary called Viva Buds Inc. to serve as the marketing arm for NLD's new retail delivery service in California. The Company will initially focus on delivering cannabis products to Southern California and then rollout to other cities statewide. NLD will contribute up to $300,000 in inventory of cannabis products to assist in the start-up of this venture and will oversee all delivery and fulfillment of orders. MCOA will provide a vast array of marketing services and technology to promote and build its Viva Buds brand.
The parties are in the process of conducting due diligence and completing a material definitive agreement.
Donald Steinberg, CEO of MCOA stated, "This partnership will enable MCOA to establish itself as a major player in the Cannabis arena. All licenses are in place to allow for vertical integration from farm to consumer. We are excited to expand our business model to now include marketing our new THC brand Viva Buds through our fully licensed partner NPE. The NPE team has a great deal of industry knowledge and has an industry disruptive business model. This is a huge strategic move for MCOA!"
Alan Tsai, NPE's CEO stated, "We are excited to become partners with MCOA as it will help us to finalize the development of our manufacturing plant faster than planned. We are aggressively focused on maximizing our market share by securing distribution, manufacturing and co-packing contracts with reputable brands throughout California. We believe that this is a crucial year for expansion in the cannabis industry in California and it's our goal to position our company as a key player in the industry in multiple verticals."
About Natural Plant Extracts of California
NPE is a fully licensed cannabis manufacturing, distribution and non-store front retail delivery. The Company has secured its licenses with the state of California and city of Lynwood, CA. For more information about the Company, please visit its website at https://nldistribution.com
The owners and founders of NPE are marijuana industry veterans with decades of experience in establishing retail, manufacturing and distribution of cannabis in California, including obtaining the first retail dispensary licenses in Los Angeles, CA.
About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name "hempSMART(TM)", that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.
About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA's jurisdiction.
Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
For more information, please visit the Company's websites at:
MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA
Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com
(END) Dow Jones Newswires
March 20, 2019 08:00 ET (12:00 GMT)
Marijuana Co. of America to buy 20% stake in Natural Plant Extract of California
PDATE: Marijuana Co. of America to buy 20% stake in NPE, to form Viva Buds JV for cannabis delivery
3/20/19 10:20 AM ET (MarketWatch)
Share
Print
Marijuana Co. of America Inc. (MCOA) announced Wednesday its intent to buy a 20% stake in Natural Plant Extract of California (NPE), and its plan to establish a joint venture operating a cannabis delivery service named Viva Buds. Under terms of a letter of intent, Marijuana Co. (MCOA) will contribute $2 million in cash and $1 million worth of its common stock. MCOA and NPE will share in the profits of Viva Buds. "This partnership will enable MCOA to establish itself as a major player in the cannabis arena," said MCOA Chief Executive Donald Steinberg. "All licenses are in place to allow for vertical integration from farm to consumer." MCOA's stock has tumbled 43.4% year to date, while the ETFMG Alternative Harvest ETF (MJ) has soared 55.3% and the S&P 500 has gained 13.0%.
“We have partnered with CBD product (manufacturers) that are complying with applicable laws and that meet CVS’s high standards for quality,” a spokesman said in the email.
Whole sector seems to be going down premarket.....
This might help boost the popularity of CBD.... https://www.msn.com/en-us/news/other/smoking-strong-pot-daily-raises-psychosis-risk-study-finds/ar-BBUZ25f?li=BBnbcA1&ocid=spartandhp
investing $2000 dollars into a stock with a mystery device. WTF was I thinking?
CGC or it's rivals should acquire Diamond CBD/potn . Their CBD products are so good they are a threat to the entire industry.
The unknown threat to the big Canadian cannabis companies is Diamond CBD/ POTN. They have CBD products so good cannabis users don't need THC at all. The taste of their products is better than any THC or CBD oils I have ever had. Taste like the best dabs you can imagine but it is organic with no butane. If I was CGC or ACB I would scoop them up ASAP before they become a serious threat..
When mainstream finds out of Diamond CBD. Big name Cannabis companies might struggle to compete. If ACB buys out Diamond CBD. It would be the best acquisition they made.
Take it from someone who has maintained being stoned on Cannabis continuously almost 24/7 since 1995. Diamond CBD is a unreal product. It is so good, I don't even need THC products anymore for my health issues and the taste is better than anything I ever tasted in my life. They have the best CBD by far hands down.
Getting close to financial report which I know is going to be amazing. Added to my position yesterday.
Nice....
I watched that stock bouncing between 4 and 5 cents for a year at least. Was always on my watch list. Wish I grabbed it.
looks like you will get those 9.75's or lower if your still looking.
edxc/CBD unlimited just had an FDA label Review. They are ready to sell in 30000 stores by 2020. IS Diamond CBD trying to do the same in regards to being FDA approved? Diamond CBD is way better the CBD unlimited products. And it is Trading at more than half the price.
Hope your right. If the target price is 10.50 to 11.25 we might have peaked for the week or even month if the MM's are taking that seriously. Usually, MMS don't buy at the target price without big news.
If this goes down during power hour..... The Peltz hype is over. We will need some new quality news soon.
ACB will be the biggest supplier in the near future. The ACB expansion plan is not fast enough It seems even though they are expanding the fastest of all CAnnabis Companies.
Canadian Pot Producers 'Underestimated' Supply Chain Demands, CEO Says
Today 11:07 AM ET (Benzinga)Print
Canadian cannabis producers struggled with supply chain issues with the rollout of legal recreational marijuana in Canada, the CEO of HEXO Corp (NYSE: HEXO) said after the company reported a surge in quarterly revenue.
"I think as a general rule, all the licensed producers including HEXO generally underestimated the amount of packaging, infrastructure and logistics, and the employees and space that it would take to actually do fulfillment," CEO Sebastien St. Louis said during a call with analysts on March 14.
HEXO reported C$13.3 million (a Canadian dollar currently is valued at US$0.75) in gross revenue, a 10-fold increase, for the second quarter of 2019, the first since Canada legalized the recreational market in 2018. The company had a net loss of C$4.3 million.
St. Louis was addressing a report from the Canadian government this week, which showed that sales of dried cannabis and cannabis oil had declined slightly in January from the previous month, while finished inventories of both grew.
The overall spread between finished inventories and sales remained wide. About 15,600 pounds of dried cannabis was sold in January, versus finished inventories of about 43,000 pounds. The spread was larger with cannabis oil, with about 7,800 liters sold versus finished inventories of about 53,000 liters.
"Where you're seeing the disconnect is basically inventory piling up from cultivation and LPs (licensed producers) not being able to process it," St. Louis said, responding to a question from BMO analyst Tamy Chen.
HEXO produced about 10,800 pounds of dried cannabis and sold about 5,900 pounds. It operates on a significantly smaller scale than market leaders Canopy Growth Corp (NYSE: CGC) and Aurora Cannabis Inc (NYSE: ACB), which respectively sold about 22,000 pounds and 14,000 pounds of marijuana during their most recent quarters.
HEXO is expanding its Belleville, Ontario, production facility and is projecting that it will help the company be able to generate up to C$400 million in sales next year.
Stocks are at an inflection point -- this is what to expect if you believe in technical analysis
Today 10:44 AM ET (MarketWatch)
Share
Print
By Nigam Arora
Keep an eye on earnings and the price action in popular tech stocks
The U.S. stock market is at an inflection point. The key question for investors is, "What is next?"
Some traditional TA (technical analysis) believers see a breakout happening.
Let us explore with the help of a chart -- if you believe in traditional technical analysis. From my view, traditional technical analysis no longer works as well as it used to; please click here (https://thearorareport.com/zyx-technical-analysis-screen/) to see the reasons.
Video:Eight tax-law changes that will most affect your 2018 return
Chart
Please click here (https://thearorareport.com/chart-stock-market-technical-analysis-breakout-20191803) for an annotated chart of S&P 500 ETF (SPY). Somewhat different conclusions are to be drawn from charts of the Dow Jones Industrial Average , Nasdaq 100 ETF (QQQ) and small-cap ETF (IWM). Please note the following:
-- The chart shows two key levels.
-- By some measures, there is a breakout above the lower key level.
-- In our analysis at The Arora Report, the breakout is suspect at this time because it is not decisive and it happened on quadruple witching, when a range of options and futures expire.
-- The chart shows five (depending upon how you count) previous attempts to break through this level have failed.
-- The chart shows The Arora Report "buy" signal on Christmas Eve at the low of the market.
-- The chart shows that The Arora Report correctly identified prior lows as "not likely lows."
-- RSI (relative strength index) shows that the overbought condition has been relieved. This augurs well for a breakout.
-- If the breakout becomes decisive, expect the market to move to the higher key level marked "resistance."
-- If the breakout fails, expect the market to move to the support zone shown on the chart.
Ask Arora: Nigam Arora answers your questions about investing in stocks, ETFs, bonds, gold and silver, oil and currencies. Have a question? Send it to Nigam Arora (mailto:ask-arora@thearorareport.com).
What to do now
Since the market is at an inflection point, in addition to watching the chart of S&P 500 , investors ought to consider the following:
-- In the long term, the single best determinant of stock prices is earnings.
-- Earnings growth is slowing. This poses serious headwinds.
-- Keep an eye on Micron Technology (MU) earnings.
-- Investors ought to consider following a proven model that has performed well in both bull and bear markets and that includes not only technical analysis but also fundamental analysis, macro and quantitative analysis.
-- Keep an eye on price action of popular tech stocks such as Apple (AAPL), Amazon (AMZN), Facebook (FB) and AMD (AMD).
-- Keep an eye on price action in recent momo (momentum) darlings such as Broadcom (AVGO), Zscaler (ZS), Etsy (ETSY) and MongoDB (MDB).
-- Keep an eye on money flows, especially smart money flows. Please see "The 'smart money' prefers Alibaba over Amazon, Intel over AMD, and Google over Apple (http://www.marketwatch.com/story/the-smart-money-prefers-alibaba-over-amazon-intel-over-amd-and-google-over-apple-2019-03-08)."
Disclosure: Subscribers to The Arora Report (http://thearorareport.com/) may have positions in the securities mentioned in this article or may take positions at any time. Nigam Arora is an investor, engineer and nuclear physicist by background who has founded two Inc. 500 fastest-growing companies. He is the founder of The Arora Report, which publishes four newsletters. Nigam can be reached at Nigam@TheAroraReport.com (mailto:Nigam@TheAroraReport.com).
-Nigam Arora; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
March 18, 2019 10:44 ET (14:44 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Target price $15 CAN is 11.25 U.S. I say 50/50 you see $9.75